[go: up one dir, main page]

AU2985499A - Non-peptide bradykinin receptor antagonists for use in treating ophthalmic diseases and disorders - Google Patents

Non-peptide bradykinin receptor antagonists for use in treating ophthalmic diseases and disorders

Info

Publication number
AU2985499A
AU2985499A AU29854/99A AU2985499A AU2985499A AU 2985499 A AU2985499 A AU 2985499A AU 29854/99 A AU29854/99 A AU 29854/99A AU 2985499 A AU2985499 A AU 2985499A AU 2985499 A AU2985499 A AU 2985499A
Authority
AU
Australia
Prior art keywords
disorders
receptor antagonists
ophthalmic diseases
bradykinin receptor
treating ophthalmic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29854/99A
Inventor
Najam Sharif
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Publication of AU2985499A publication Critical patent/AU2985499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU29854/99A 1998-04-03 1999-03-04 Non-peptide bradykinin receptor antagonists for use in treating ophthalmic diseases and disorders Abandoned AU2985499A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8000398P 1998-04-03 1998-04-03
US60080003 1998-04-03
PCT/US1999/004866 WO1999051245A1 (en) 1998-04-03 1999-03-04 Non-peptide bradykinin receptor antagonists for use in treating ophthalmic diseases and disorders

Publications (1)

Publication Number Publication Date
AU2985499A true AU2985499A (en) 1999-10-25

Family

ID=22154279

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29854/99A Abandoned AU2985499A (en) 1998-04-03 1999-03-04 Non-peptide bradykinin receptor antagonists for use in treating ophthalmic diseases and disorders

Country Status (4)

Country Link
US (1) US6531480B1 (en)
AR (1) AR018825A1 (en)
AU (1) AU2985499A (en)
WO (1) WO1999051245A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU680870B2 (en) 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
US20070225225A1 (en) * 2006-02-28 2007-09-27 Sharif Najam A Use of natriuretic peptide receptor antagonists to treat ocular, otic and nasal edemetous conditions
US20080160366A1 (en) * 2006-12-29 2008-07-03 Allen Glenn M Porous plate for a fuel cell

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646773B1 (en) 1989-05-12 1994-05-13 Chauvin Sa Laboratoire PHARMACEUTICAL COMPOSITION BASED ON PARACETAMOL
EP0529499A1 (en) * 1991-08-22 1993-03-03 Hoechst Aktiengesellschaft Compositions for topical administration to the nose or the eyes containing bradykinin antagonists
JPH10316677A (en) * 1997-05-19 1998-12-02 Fujisawa Pharmaceut Co Ltd Crystal

Also Published As

Publication number Publication date
WO1999051245A1 (en) 1999-10-14
US6531480B1 (en) 2003-03-11
AR018825A1 (en) 2001-12-12

Similar Documents

Publication Publication Date Title
HK1046274A1 (en) Spiro Ä1-azabicycloÄ2.2.2.Üoctane-3,2'(3'h)-furoÄ2,3-bÜpyridine for use in the treatment of psychotic and intellectual impairment disorders.
EP1233728A4 (en) Ophthalmic device and method of manufacture and use
AU6894600A (en) Therapeutic polypeptides and methods for using same
AU4713499A (en) Ophthalmic uses of ppargamma agonists and ppargamma antagonists
AU2072201A (en) Agents and methods for the treatment of proliferative diseases
AU4325499A (en) Receptor ligand antagonist complexes and their use in treating or preventing receptor mediated diseases
AU2002317105A1 (en) Methods for identifying therapeutic agents for treating diseases involving wnt polypeptides and wnt receptors
ZA964762B (en) Peptidyl heterocycles useful in the treatment of thrombin related disorders.
EP1213018A4 (en) Preventive and therapeutic agents for eye diseases
ZA964761B (en) Peptidyl heterocycles useful in the treatment of thrombin related disorders.
IL120477A0 (en) Fluoroalkyl - and fluoroalkoxy-substituted heterocyclic bradykinin antagonists process for their preparation and their use
AU5774699A (en) Human stearoyl-coa desaturase-related compositions and methods for treating skin disorders
IL162475A0 (en) Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists
GB9712761D0 (en) Quinolines and their therapeutic use
AU2985499A (en) Non-peptide bradykinin receptor antagonists for use in treating ophthalmic diseases and disorders
AU4768899A (en) Peptide antagonists of the human urokinase receptor and method for selecting them
AU6281298A (en) Use of lofexidine in the treatment of behavioral disorders
AU2985399A (en) Non-peptide bradykinin receptor antagonists for use in controlling intraocular pressure and treating glaucoma
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AU3116697A (en) Human interleukin-1j and antagonists thereof
GB9826276D0 (en) Therapeutic agents for use in degenerative disorders
AU1146401A (en) Use of 5ht-1a-serotonine receptor agonists for treating genetic or functional rhythm disorders in the respiratory system
AU8667898A (en) Use of alpha1a-adrenergic receptor antagonists in glaucoma therapy
EP0878200A4 (en) Therapeutic agent for ophthalmic diseases
AU4537199A (en) Device for laser therapy in ophthalmology and variants

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase